CERo Therapeutics Holdings, Inc. ( CERO) - Stock Earnings
CERO Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -4.9 million USD | — USD |
| 2025Q4 | -4.5 million USD | — USD |
| 2026Q1 | -5.9 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
CERO Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -2536 USD | — USD |
| 2024 | -7.7 million USD | — USD |
| 2025 | -19.9 million USD | — USD |
| 2026 Est. | — | — |
CERO
Price: $0.01
52 week price:
Earnings Per Share: 9.04 USD
P/E Ratio: 0.00
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 541348